[1]
|
Ago, Y., Arikawa, S., Yata, M., Yano, K., Abe, M., Takuma, K., & Matsuda, T. (2008). Antidepressant-Like Effects of the Glucocorticoid Receptor Antagonist RU-43044 Are Associated with Changes in Prefrontal Dopamine in Mouse Models of Depression. Neuropharmacology, 55, 1355-1363. https://doi.org/10.1016/j.neuropharm.2008.08.026
|
[2]
|
Atagun, M. I., Sikoglu, E. M., Soykan, C., Serdar Suleyman, C., Ulusoy-Kaymak, S., Caykoylu, A., Moore, C. M. et al. (2017). Perisylvian GABA Levels in Schizophrenia and Bipolar Disorder. Neuroscience Letters, 637, 70-74. https://doi.org/10.1016/j.neulet.2016.11.051
|
[3]
|
Banasr, M., Lepack, A., Fee, C., Duric, V., Maldonado-Aviles, J., DiLeone, R., Sanacora, G. et al. (2017). Characterization of GABAergic Marker Expression in the Chronic Unpredictable Stress Model of Depression. Chronic Stress (Thousand Oaks), 1. https://doi.org/10.1177/2470547017720459
|
[4]
|
Barja, G. (2002). Endogenous Oxidative Stress: Relationship to Aging, Longevity and Caloric Restriction. Ageing Research Reviews, 1, 397-411. https://doi.org/10.1016/S1568-1637(02)00008-9
|
[5]
|
Bowley, M. P., Drevets, W. C., Ongur, D., & Price, J. L. (2002). Low Glial Numbers in the Amygdala in Major Depressive Disorder. Biological Psychiatry, 52, 404-412. https://doi.org/10.1016/S0006-3223(02)01404-X
|
[6]
|
Brown, M. R., Rivier, C., & Vale, W. (1984). Central Nervous System Regulation of Adrenocorticotropin Secretion: Role of Somatostatins. Endocrinology, 114, 1546-1549. https://doi.org/10.1210/endo-114-5-1546
|
[7]
|
Bruunsgaard, H., & Pedersen, B. K. (2003). Age-Related Inflammatory Cytokines and Disease. Immunology and Allergy Clinics of North America, 23, 15-39. https://doi.org/10.1016/S0889-8561(02)00056-5
|
[8]
|
Campbell, S., Marriott, M., Nahmias, C., & MacQueen, G. M. (2004). Lower Hippocampal Volume in Patients Suffering from Depression: A Meta-Analysis. American Journal of Psychiatry, 161, 598-607. https://doi.org/10.1176/appi.ajp.161.4.598
|
[9]
|
Czeh, B., Varga, Z. K., Henningsen, K., Kovacs, G. L., Miseta, A., & Wiborg, O. (2015). Chronic Stress Reduces the Number of GABAergic Interneurons in the Adult Rat Hippocampus, Dorsal-Ventral and Region-Specific Differences. Hippocampus, 25, 393-405. https://doi.org/10.1002/hipo.22382
|
[10]
|
Douillard-Guilloux, G., Guilloux, J. P., Lewis, D. A., & Sibille, E. (2013). Anticipated Brain Molecular Aging in Major Depression. The American Journal of Geriatric Psychiatry, 21, 450-460. https://doi.org/10.1016/j.jagp.2013.01.040
|
[11]
|
Douillard-Guilloux, G., Lewis, D., Seney, M. L., & Sibille, E. (2017). Decrease in Somatostatin-Positive Cell Density in the Amygdala of Females with Major Depression. Depress Anxiety, 34, 68-78. https://doi.org/10.1002/da.22549
|
[12]
|
Du, X., Serena, K., Hwang, W., Grech, A. M., Wu, Y. W. C., Schroeder, A., & Hill, R. A. (2018). Prefrontal Cortical Parvalbumin and Somatostatin Expression and Cell Density Increase during Adolescence and Are Modified by BDNF and Sex. Molecular and Cellular Neuroscience, 88, 177-188. https://doi.org/10.1016/j.mcn.2018.02.001
|
[13]
|
Dubin, M. J., Mao, X., Banerjee, S., Goodman, Z., Lapidus, K. A., Kang, G., Shungu, D. C. et al. (2016). Elevated Prefrontal Cortex GABA in Patients with Major Depressive Disorder after TMS Treatment Measured with Proton Magnetic Resonance Spectroscopy. Journal of Psychiatry & Neuroscience, 41, E37-E45. https://doi.org/10.1503/jpn.150223
|
[14]
|
Ebmeier, K. P., Donaghey, C., & Steele, J. D. (2006). Recent Developments and Current Controversies in Depression. The Lancet, 367, 153-167. https://doi.org/10.1016/S0140-6736(06)67964-6
|
[15]
|
Engin, E., & Treit, D. (2009). Anxiolytic and Antidepressant Actions of Somatostatin: The Role of sst2 and sst3 Receptors. Psychopharmacology (Berl), 206, 281-289. https://doi.org/10.1007/s00213-009-1605-5
|
[16]
|
Engin, E., Stellbrink, J., Treit, D., & Dickson, C. T. (2008). Anxiolytic and Antidepressant Effects of Intracerebroventricularly Administered Somatostatin: Behavioral and Neurophysiological Evidence. Neuroscience, 157, 666-676. https://doi.org/10.1016/j.neuroscience.2008.09.037
|
[17]
|
Erickson, K. I., Prakash, R. S., Voss, M. W., Chaddock, L., Heo, S., McLaren, M., Kramer, A. F. et al. (2010). Brain-Derived Neurotrophic Factor Is Associated with Age-Related Decline in Hippocampal Volume. Journal of Neuroscience, 30, 5368-5375. https://doi.org/10.1523/JNEUROSCI.6251-09.2010
|
[18]
|
Erraji-Benchekroun, L., Underwood, M. D., Arango, V., Galfalvy, H., Pavlidis, P., Smyrniotopoulos, P., Sibille, E. et al. (2005). Molecular Aging in Human Prefrontal Cortex Is Selective and Continuous throughout Adult Life. Biological Psychiatry, 57, 549-558. https://doi.org/10.1016/j.biopsych.2004.10.034
|
[19]
|
Faron-Gorecka, A., Kusmider, M., Kolasa, M., Zurawek, D., Szafran-Pilch, K., Gruca, P., Dziedzicka-Wasylewska, M. et al. (2016). Chronic Mild Stress Alters the Somatostatin Receptors in the Rat Brain. Psychopharmacology (Berl), 233, 255-266. https://doi.org/10.1007/s00213-015-4103-y
|
[20]
|
Faron-Gorecka, A., Kusmider, M., Solich, J., Kolasa, M., Pabian, P., Gruca, P., Dziedzicka-Wasylewska, M. et al. (2018). Regulation of Somatostatin Receptor 2 in the Context of Antidepressant Treatment Response in Chronic Mild Stress in Rat. Psychopharmacology (Berl), 235, 2137-2149. https://doi.org/10.1007/s00213-018-4912-x
|
[21]
|
Fino, E., Packer, A. M., & Yuste, R. (2013). The Logic of Inhibitory Connectivity in the Neocortex. Neuroscientist, 19, 228-237. https://doi.org/10.1177/1073858412456743
|
[22]
|
Fisher, D. A., & Brown, M. R. (1980). Somatostatin Analog: Plasma Catecholamine Suppression Mediated by the Central Nervous System. Endocrinology, 107, 714-718. https://doi.org/10.1210/endo-107-3-714
|
[23]
|
French, L., Ma, T., Oh, H., Tseng, G. C., & Sibille, E. (2017). Age-Related Gene Expression in the Frontal Cortex Suggests Synaptic Function Changes in Specific Inhibitory Neuron Subtypes. Frontiers in Aging Neuroscience, 9, 162. https://doi.org/10.3389/fnagi.2017.00162
|
[24]
|
Fuchs, T., Jefferson, S. J., Hooper, A., Yee, P. H., Maguire, J., & Luscher, B. (2017). Disinhibition of Somatostatin-Positive GABAergic Interneurons Results in an Anxiolytic and Antidepressant-Like Brain State. Molecular Psychiatry, 22, 920-930. https://doi.org/10.1038/mp.2016.188
|
[25]
|
Gabbay, V., Mao, X., Klein, R. G., Ely, B. A., Babb, J. S., Panzer, A. M., Shungu, D. C. et al. (2012). Anterior Cingulate Cortex Gamma-Aminobutyric Acid in Depressed Adolescents: Relationship to Anhedonia. Archives of General Psychiatry, 69, 139-149. https://doi.org/10.1001/archgenpsychiatry.2011.131
|
[26]
|
Gentet, L. J., Kremer, Y., Taniguchi, H., Huang, Z. J., Staiger, J. F., & Petersen, C. C. (2012). Unique Functional Properties of Somatostatin-Expressing GABAergic Neurons in Mouse Barrel Cortex. Nature Neuroscience, 15, 607-612. https://doi.org/10.1038/nn.3051
|
[27]
|
Glorioso, C., Oh, S., Douillard, G. G., & Sibille, E. (2011). Brain Molecular Aging, Promotion of Neurological Disease and Modulation by Sirtuin 5 Longevity Gene Polymorphism. Neurobiology of Disease, 41, 279-290. https://doi.org/10.1016/j.nbd.2010.09.016
|
[28]
|
Glorioso, C., Sabatini, M., Unger, T., Hashimoto, T., Monteggia, L. M., Lewis, D. A., & Mirnics, K. (2006). Specificity and Timing of Neocortical Transcriptome Changes in Response to BDNF Gene Ablation during Embryogenesis or Adulthood. Molecular Psychiatry, 11, 633-648. https://doi.org/10.1038/sj.mp.4001835
|
[29]
|
Gonchar, Y., & Burkhalter, A. (1997). Three Distinct Families of GABAergic Neurons in Rat Visual Cortex. Cerebral Cortex, 7, 347-358. https://doi.org/10.1093/cercor/7.4.347
|
[30]
|
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008). Brain Interleukin-1 Mediates Chronic Stress-Induced Depression in Mice via Adrenocortical Activation and Hippocampal Neurogenesis Suppression. Molecular Psychiatry, 13, 717-728. https://doi.org/10.1038/sj.mp.4002055
|
[31]
|
Guilloux, J. P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., Sibille, E. et al. (2012). Molecular Evidence for BDNF- and GABA-Related Dysfunctions in the Amygdala of Female Subjects with Major Depression. Molecular Psychiatry, 17, 1130-1142. https://doi.org/10.1038/mp.2011.113
|
[32]
|
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018). Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. JAMA Psychiatry, 75, 336-346. https://doi.org/10.1001/jamapsychiatry.2017.4602
|
[33]
|
Herman, J. P., Ostrander, M. M., Mueller, N. K., & Figueiredo, H. (2005). Limbic System Mechanisms of Stress Regulation: Hypothalamo-Pituitary-Adrenocortical Axis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 1201-1213. https://doi.org/10.1016/j.pnpbp.2005.08.006
|
[34]
|
Hirschfeld, R. M. (2000). History and Evolution of the Monoamine Hypothesis of Depression. The Journal of Clinical Psychiatry, 61, 4-6.
|
[35]
|
Hu, W., Zhang, M., Czeh, B., Flugge, G., & Zhang, W. (2010). Stress Impairs GABAergic Network Function in the Hippocampus by Activating Nongenomic Glucocorticoid Receptors and Affecting the Integrity of the Parvalbumin-Expressing Neuronal Network. Neuropsychopharmacology, 35, 1693-1707. https://doi.org/10.1038/npp.2010.31
|
[36]
|
Jaglin, X. H., Hjerling-Leffler, J., Fishell, G., & Batista-Brito, R. (2012). The Origin of Neocortical Nitric Oxide Synthase-Expressing Inhibitory Neurons. Frontiers in Neural Circuits, 6, 44. https://doi.org/10.3389/fncir.2012.00044
|
[37]
|
Karolewicz, B., Maciag, D., O’Dwyer, G., Stockmeier, C. A., Feyissa, A. M., & Rajkowska, G. (2010). Reduced Level of Glutamic Acid Decarboxylase-67 kDa in the Prefrontal Cortex in Major Depression. International Journal of Neuropsychopharmacology, 13, 411-420. https://doi.org/10.1017/S1461145709990587
|
[38]
|
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017). HPA Axis in Major Depression: Cortisol, Clinical Symptomatology and Genetic Variation Predict Cognition. Molecular Psychiatry, 22, 527-536. https://doi.org/10.1038/mp.2016.120
|
[39]
|
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., National Comorbidity Survey, R. et al. (2003). The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289, 3095-3105. https://doi.org/10.1001/jama.289.23.3095
|
[40]
|
Klumpers, U. M., Veltman, D. J., Drent, M. L., Boellaard, R., Comans, E. F., Meynen, G., Hoogendijk, W. J. et al. (2010). Reduced Parahippocampal and Lateral Temporal GABAA-[11C]flumazenil Binding in Major Depression: Preliminary Results. European Journal of Nuclear Medicine and Molecular Imaging, 37, 565-574. https://doi.org/10.1007/s00259-009-1292-9
|
[41]
|
Lewis, D. A., & Sweet, R. A. (2009). Schizophrenia from a Neural Circuitry Perspective: Advancing toward Rational Pharmacological Therapies. The Journal of Clinical Investigation, 119, 706-716. https://doi.org/10.1172/JCI37335
|
[42]
|
Li, W., Papilloud, A., Lozano-Montes, L., Zhao, N., Ye, X., Zhang, X., Rainer, G. et al. (2018). Stress Impacts the Regulation Neuropeptides in the Rat Hippocampus and Prefrontal Cortex. Proteomics, 18, e1700408. https://doi.org/10.1002/pmic.201700408
|
[43]
|
Lin, L. C., & Sibille, E. (2013). Reduced Brain Somatostatin in Mood Disorders: A Common Pathophysiological Substrate and Drug Target? Frontiers in Pharmacology, 4, 110. https://doi.org/10.3389/fphar.2013.00110
|
[44]
|
Lin, L. C., & Sibille, E. (2015). Somatostatin, Neuronal Vulnerability and Behavioral Emotionality. Molecular Psychiatry, 20, 377-387. https://doi.org/10.1038/mp.2014.184
|
[45]
|
Ma, Y., Hu, H., Berrebi, A. S., Mathers, P. H., & Agmon, A. (2006). Distinct Subtypes of Somatostatin-Containing Neocortical Interneurons Revealed in Transgenic Mice. Journal of Neuroscience, 26, 5069-5082. https://doi.org/10.1523/JNEUROSCI.0661-06.2006
|
[46]
|
Machado-Vieira, R., Salvadore, G., DiazGranados, N., & Zarate, C. A. (2009). Ketamine and the Next Generation of Antidepressants with a Rapid Onset of Action. Pharmacology & Therapeutics, 123, 143-150. https://doi.org/10.1016/j.pharmthera.2009.02.010
|
[47]
|
Marathe, S. V., D’Almeida P, L., Virmani, G., Bathini, P., & Alberi, L. (2018). Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression. Journal of Experimental Neuroscience, 12, 1179069518789149. https://doi.org/10.1177/1179069518789149
|
[48]
|
Martinowich, K., Schloesser, R. J., Jimenez, D. V., Weinberger, D. R., & Lu, B. (2011). Activity-Dependent Brain-Derived Neurotrophic Factor Expression Regulates Cortistatin-Interneurons and Sleep Behavior. Molecular Brain, 4, 11. https://doi.org/10.1186/1756-6606-4-11
|
[49]
|
Mayberg, H. S. (2002). Modulating Limbic-Cortical Circuits in Depression: Targets of Antidepressant Treatments. Seminars in Clinical Neuropsychiatry, 7, 255-268. https://doi.org/10.1053/scnp.2002.35223
|
[50]
|
McEwen, B. S., Nasca, C., & Gray, J. D. (2016). Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex. Neuropsychopharmacology, 41, 3-23. https://doi.org/10.1038/npp.2015.171
|
[51]
|
Millan, M. J. (2006). Multi-Target Strategies for the Improved Treatment of Depressive States: Conceptual Foundations and Neuronal Substrates, Drug Discovery and Therapeutic Application. Pharmacology & Therapeutics, 110, 135-370. https://doi.org/10.1016/j.pharmthera.2005.11.006
|
[52]
|
Molchan, S. E., Lawlor, B. A., Hill, J. L., Martinez, R. A., Davis, C. L., Mellow, A. M., Sunderland, T. et al. (1991). CSF Monoamine Metabolites and Somatostatin in Alzheimer’s Disease and Major Depression. Biological Psychiatry, 29, 1110-1118. https://doi.org/10.1016/0006-3223(91)90253-I
|
[53]
|
Murayama, M., Perez-Garci, E., Nevian, T., Bock, T., Senn, W., & Larkum, M. E. (2009). Dendritic Encoding of Sensory Stimuli Controlled by Deep Cortical Interneurons. Nature, 457, 1137-1141. https://doi.org/10.1038/nature07663
|
[54]
|
Nilsson, A., Stroth, N., Zhang, X., Qi, H., Falth, M., Skold, K., Svenningsson, P. et al. (2012). Neuropeptidomics of Mouse Hypothalamus after Imipramine Treatment Reveal Somatostatin as a Potential Mediator of Antidepressant Effects. Neuropharmacology, 62, 347-357. https://doi.org/10.1016/j.neuropharm.2011.08.004
|
[55]
|
Pallis, E., Vasilaki, A., Fehlmann, D., Kastellakis, A., Hoyer, D., Spyraki, C., & Thermos, K. (2009). Antidepressants Influence Somatostatin Levels and Receptor Pharmacology in Brain. Neuropsychopharmacology, 34, 952-963. https://doi.org/10.1038/npp.2008.133
|
[56]
|
Pariante, C. M., & Lightman, S. L. (2008). The HPA Axis in Major Depression: Classical Theories and New Developments. Trends in Neurosciences, 31, 464-468. https://doi.org/10.1016/j.tins.2008.06.006
|
[57]
|
Ponomarev, I., Rau, V., Eger, E. I., Harris, R. A., & Fanselow, M. S. (2010). Amygdala Transcriptome and Cellular Mechanisms Underlying Stress-Enhanced Fear Learning in a Rat Model of Posttraumatic Stress Disorder. Neuropsychopharmacology, 35, 1402-1411. https://doi.org/10.1038/npp.2010.10
|
[58]
|
Post, R. M., Rubinow, D. R., Kling, M. A., Berrettini, W., & Gold, P. W. (1988). Neuroactive Substances in Cerebrospinal Fluid. Normal and Pathological Regulatory Mechanisms. Annals of the New York Academy of Sciences, 531, 15-28. https://doi.org/10.1111/j.1749-6632.1988.tb31808.x
|
[59]
|
Prevot, T. D., Gastambide, F., Viollet, C., Henkous, N., Martel, G., Epelbaum, J., Guillou, J. L. et al. (2017). Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality. Neuropsychopharmacology, 42, 1647-1656. https://doi.org/10.1038/npp.2016.281
|
[60]
|
Prevot, T. D., Viollet, C., Epelbaum, J., Dominguez, G., Beracochea, D., & Guillou, J. L. (2018). sst2-Receptor Gene Deletion Exacerbates Chronic Stress-Induced Deficits: Consequences for Emotional and Cognitive Ageing. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 86, 390-400. https://doi.org/10.1016/j.pnpbp.2018.01.022
|
[61]
|
Rajkowska, G., Halaris, A., & Selemon, L. D. (2001). Reductions in Neuronal and Glial Density Characterize the Dorsolateral Prefrontal Cortex in Bipolar Disorder. Biological Psychiatry, 49, 741-752. https://doi.org/10.1016/S0006-3223(01)01080-0
|
[62]
|
Ren, Z., Pribiag, H., Jefferson, S. J., Shorey, M., Fuchs, T., Stellwagen, D., & Luscher, B. (2016). Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment. Biological Psychiatry, 80, 457-468. https://doi.org/10.1016/j.biopsych.2016.02.009
|
[63]
|
Rozycka, A., & Liguz-Lecznar, M. (2017). The Space Where Aging Acts: Focus on the GABAergic Synapse. Aging Cell, 16, 634-643. https://doi.org/10.1111/acel.12605
|
[64]
|
Rudy, B., Fishell, G., Lee, S., & Hjerling-Leffler, J. (2011). Three Groups of Interneurons Account for Nearly 100% of Neocortical GABAergic Neurons. Developmental Neurobiology, 71, 45-61. https://doi.org/10.1002/dneu.20853
|
[65]
|
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Fava, M. et al. (2006). Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. American Journal of Psychiatry, 163, 1905-1917. https://doi.org/10.1176/ajp.2006.163.11.1905
|
[66]
|
Sanacora, G., Fenton, L. R., Fasula, M. K., Rothman, D. L., Levin, Y., Krystal, J. H., & Mason, G. F. (2006). Cortical Gamma-Aminobutyric Acid Concentrations in Depressed Patients Receiving Cognitive Behavioral Therapy. Biological Psychiatry, 59, 284-286. https://doi.org/10.1016/j.biopsych.2005.07.015
|
[67]
|
Sanacora, G., Mason, G. F., Rothman, D. L., Hyder, F., Ciarcia, J. J., Ostroff, R. B., Krystal, J. H. et al. (2003). Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT. American Journal of Psychiatry, 160, 577-579. https://doi.org/10.1176/appi.ajp.160.3.577
|
[68]
|
Scheich, B., Cseko, K., Borbely, E., Abraham, I., Csernus, V., Gaszner, B., & Helyes, Z. (2017). Higher Susceptibility of Somatostatin 4 Receptor Gene-Deleted Mice to Chronic Stress-Induced Behavioral and Neuroendocrine Alterations. Neuroscience, 346, 320-336. https://doi.org/10.1016/j.neuroscience.2017.01.039
|
[69]
|
Scheich, B., Gaszner, B., Kormos, V., Laszlo, K., Adori, C., Borbely, E., Helyes, Z. et al. (2016). Somatostatin Receptor Subtype 4 Activation Is Involved in Anxiety and Depression-Like Behavior in Mouse Models. Neuropharmacology, 101, 204-215. https://doi.org/10.1016/j.neuropharm.2015.09.021
|
[70]
|
Seney, M. L., Chang, L. C., Oh, H., Wang, X., Tseng, G. C., Lewis, D. A., & Sibille, E. (2013). The Role of Genetic Sex in Affect Regulation and Expression of GABA-Related Genes across Species. Frontiers in Psychiatry, 4, 104. https://doi.org/10.3389/fpsyt.2013.00104
|
[71]
|
Seney, M. L., Tripp, A., McCune, S., Lewis, D. A., & Sibille, E. (2015). Laminar and Cellular Analyses of Reduced Somatostatin Gene Expression in the Subgenual Anterior Cingulate Cortex in Major Depression. Neurobiology of Disease, 73, 213-219. https://doi.org/10.1016/j.nbd.2014.10.005
|
[72]
|
Sheline, Y. I. (1996). Hippocampal Atrophy in Major Depression: A Result of Depression-Induced Neurotoxicity? Molecular Psychiatry, 1, 298-299.
|
[73]
|
Shen, Q., Lal, R., Luellen, B. A., Earnheart, J. C., Andrews, A. M., & Luscher, B. (2010). Gamma-Aminobutyric Acid-Type A Receptor Deficits Cause Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Antidepressant Drug Sensitivity Reminiscent of Melancholic Forms of Depression. Biological Psychiatry, 68, 512-520. https://doi.org/10.1016/j.biopsych.2010.04.024
|
[74]
|
Shirayama, Y., Chen, A. C., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002). Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression. Journal of Neuroscience, 22, 3251-3261. https://doi.org/10.1523/JNEUROSCI.22-08-03251.2002
|
[75]
|
Sibille, E., Morris, H. M., Kota, R. S., & Lewis, D. A. (2011). GABA-Related Transcripts in the Dorsolateral Prefrontal Cortex in Mood Disorders. International Journal of Neuropsychopharmacology, 14, 721-734. https://doi.org/10.1017/S1461145710001616
|
[76]
|
Sibille, E., Wang, Y., Joeyen-Waldorf, J., Gaiteri, C., Surget, A., Oh, S., Lewis, D. A. et al. (2009). A Molecular Signature of Depression in the Amygdala. American Journal of Psychiatry, 166, 1011-1024. https://doi.org/10.1176/appi.ajp.2009.08121760
|
[77]
|
Song, C., & Wang, H. (2011). Cytokines Mediated Inflammation and Decreased Neurogenesis in Animal Models of Depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 760-768. https://doi.org/10.1016/j.pnpbp.2010.06.020
|
[78]
|
Soumier, A., & Sibille, E. (2014). Opposing Effects of Acute versus Chronic Blockade of Frontal Cortex Somatostatin-Positive Inhibitory Neurons on Behavioral Emotionality in Mice. Neuropsychopharmacology, 39, 2252-2262. https://doi.org/10.1038/npp.2014.76
|
[79]
|
Szafran-Pilch, K., Faron-Gorecka, A., Kolasa, M., Zurawek, D., Szlachta, M., Solich, J., Dziedzicka-Wasylewska, M. et al. (2017). Antidepressants Promote Formation of Heterocomplexes of Dopamine D2 and Somatostatin Subtype 5 Receptors in the Mouse Striatum. Brain Research Bulletin, 135, 92-97. https://doi.org/10.1016/j.brainresbull.2017.10.003
|
[80]
|
Thompson Ray, M., Weickert, C. S., Wyatt, E., & Webster, M. J. (2011). Decreased BDNF, trkB-TK+ and GAD67 mRNA Expression in the Hippocampus of Individuals with Schizophrenia and Mood Disorders. Journal of Psychiatry & Neuroscience, 36, 195-203. https://doi.org/10.1503/jpn.100048
|
[81]
|
Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X. (2015). An Excitatory Synapse Hypothesis of Depression. Trends in Neurosciences, 38, 279-294. https://doi.org/10.1016/j.tins.2015.03.003
|
[82]
|
Tripp, A., Kota, R. S., Lewis, D. A., & Sibille, E. (2011). Reduced Somatostatin in Subgenual Anterior Cingulate Cortex in Major Depression. Neurobiology of Disease, 42, 116-124. https://doi.org/10.1016/j.nbd.2011.01.014
|
[83]
|
Tripp, A., Oh, H., Guilloux, J. P., Martinowich, K., Lewis, D. A., & Sibille, E. (2012). Brain-Derived Neurotrophic Factor Signaling and Subgenual Anterior Cingulate Cortex Dysfunction in Major Depressive Disorder. American Journal of Psychiatry, 169, 1194-1202. https://doi.org/10.1176/appi.ajp.2012.12020248
|
[84]
|
Valentine, G. W., & Sanacora, G. (2009). Targeting Glial Physiology and Glutamate Cycling in the Treatment of Depression. Biochemical Pharmacology, 78, 431-439. https://doi.org/10.1016/j.bcp.2009.04.008
|
[85]
|
Vincent, M. Y., Hussain, R. J., Zampi, M. E., Sheeran, K., Solomon, M. B., Herman, J. P., Jacobson, L. et al. (2013). Sensitivity of Depression-Like Behavior to Glucocorticoids and Antidepressants Is Independent of Forebrain Glucocorticoid Receptors. Brain Research, 1525, 1-15. https://doi.org/10.1016/j.brainres.2013.05.031
|
[86]
|
Viollet, C., Lepousez, G., Loudes, C., Videau, C., Simon, A., & Epelbaum, J. (2008). Somatostatinergic Systems in Brain: Networks and Functions. Molecular and Cellular Endocrinology, 286, 75-87. https://doi.org/10.1016/j.mce.2007.09.007
|
[87]
|
Viollet, C., Vaillend, C., Videau, C., Bluet-Pajot, M. T., Ungerer, A., L’Heritier, A., Epelbaum, J. et al. (2000). Involvement of sst2 Somatostatin Receptor in Locomotor, Exploratory Activity and Emotional Reactivity in Mice. European Journal of Neuroscience, 12, 3761-3770. https://doi.org/10.1046/j.1460-9568.2000.00249.x
|
[88]
|
Wang, J., Jing, L., Toledo-Salas, J. C., & Xu, L. (2015). Rapid-Onset Antidepressant Efficacy of Glutamatergic System Modulators: The Neural Plasticity Hypothesis of Depression. Neuroscience Bulletin, 31, 75-86. https://doi.org/10.1007/s12264-014-1484-6
|
[89]
|
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003). Opportunities in Somatostatin Research: Biological, Chemical and Therapeutic Aspects. Nature Reviews Drug Discovery, 2, 999-1017. https://doi.org/10.1038/nrd1255
|
[90]
|
Wohleb, E. S., Wu, M., Gerhard, D. M., Taylor, S. R., Picciotto, M. R., Alreja, M., & Duman, R. S. (2016). GABA Interneurons Mediate the Rapid Antidepressant-Like Effects of Scopolamine. The Journal of Clinical Investigation, 126, 2482-2494. https://doi.org/10.1172/JCI85033
|
[91]
|
Xu, H., Jeong, H. Y., Tremblay, R., & Rudy, B. (2013). Neocortical Somatostatin-Expressing GABAergic Interneurons Disinhibit the Thalamorecipient Layer 4. Neuron, 77, 155-167. https://doi.org/10.1016/j.neuron.2012.11.004
|
[92]
|
Yeung, M., & Treit, D. (2012). The Anxiolytic Effects of Somatostatin Following Intra-Septal and Intra-Amygdalar Microinfusions Are Reversed by the Selective sst2 Antagonist PRL2903. Pharmacology Biochemistry and Behavior, 101, 88-92. https://doi.org/10.1016/j.pbb.2011.12.012
|
[93]
|
Yeung, M., Engin, E., & Treit, D. (2011). Anxiolytic-Like Effects of Somatostatin Isoforms SST 14 and SST 28 in Two Animal Models (Rattus norvegicus) after Intra-Amygdalar and Intra-Septal Microinfusions. Psychopharmacology (Berl), 216, 557-567. https://doi.org/10.1007/s00213-011-2248-x
|
[94]
|
Zarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Luckenbaugh, D. A. et al. (2012). Replication of Ketamine’s Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial. Biological Psychiatry, 71, 939-946. https://doi.org/10.1016/j.biopsych.2011.12.010
|